- New treatments for chronic hepatitis C
-
Jang JY, Chung RT
- KMID: 1717320
- Korean J Hepatol.
- 2010 Sep;16(3):263-277.
- doi: 10.3350/kjhep.2010.16.3.263
Treatments for chronic hepatitis C has evolved significantly in the past 15 years. The standard of care (SOC) is peginterferon alfa-2a/-2b with ribavirin for 48 weeks or 24 weeks in... -
- CITED
-
- Close
- SHARE
-
- Close
- Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients
-
Chung GE, Cho EJ, Lee JH, Yoo JJ, Lee M, Cho Y, Lee DH, Kim HY, Yu SJ, Kim YJ, Yoon JH, Zoulim F
- KMID: 2412116
- Clin Mol Hepatol.
- 2017 Mar;23(1):66-73.
- doi: 10.3350/cmh.2016.0060
BACKGROUND/AIMS: A recent study reported that entecavir had inferior efficacy in nucleos(t)ide analogue (NA)-experienced chronic hepatitis B (CHB) patients compared to NA-naïve patients. We sought to compare the efficacy of... -
- CITED
-
- Close
- SHARE
-
- Close
